Below are the top small-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.
Lannett Company LCI is likely to earn $2.08 per share in the next year ending June, 2015. Lannett's trailing-twelve-month operating margin is 13.06%.
POZEN POZN may earn $1.28 per share in the next year ending December, 2015. POZEN's PEG ratio is 0.43.
DepoMed DEPO is projected to earn $0.51 per share for the next year ending December, 2015. DepoMed's trailing-twelve-month revenue is $120.19 million.
SciClone Pharmaceuticals SCLN is expected to earn $0.45 per share over the next year ending December, 2015. SciClone Pharma's trailing-twelve-month ROE is 8.71%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in